Breaking

— OncoSil Medical Plans ASX Share Placement to Raise Capital — Boy with rare genetic condition meets donor whose bone marrow saved his life — Boy with rare genetic condition meets donor whose bone marrow saved his life — Boy with rare genetic condition meets donor whose bone marrow saved his life — Hagihara Industries Forms Growth-Focused Alliance With DBJ and Issues Shares — OncoSil Medical Plans ASX Share Placement to Raise Capital — Boy with rare genetic condition meets donor whose bone marrow saved his life — Boy with rare genetic condition meets donor whose bone marrow saved his life — Boy with rare genetic condition meets donor whose bone marrow saved his life — Hagihara Industries Forms Growth-Focused Alliance With DBJ and Issues Shares

Uncategorized

September 7, 2026

Uncategorized

OncoSil Medical Plans ASX Share Placement to Raise Capital

OncoSil Medical Ltd ( (AU:OSL) ) has issued an update. OncoSil Medical Ltd has announced a proposed placement of up to 4,000,000 ordinary fully paid shares on the ASX. The new securities are scheduled for issue on 10 September 2026, subject to ASX processes and quotation. The capital raising via this share placement is intended […]

By ijnn_world · IJNN Contributing Reporter · September 7, 2026

OncoSil Medical Ltd ( (AU:OSL) ) has issued an update.

OncoSil Medical Ltd has announced a proposed placement of up to 4,000,000 ordinary fully paid shares on the ASX. The new securities are scheduled for issue on 10 September 2026, subject to ASX processes and quotation.

The capital raising via this share placement is intended to support OncoSil Medical’s ongoing operations and growth initiatives. The move may lead to share dilution for existing shareholders but provides the company with additional funding flexibility in a competitive medical technology market.

More about OncoSil Medical Ltd OncoSil Medical Ltd is a listed medical technology company focused on developing and commercialising oncology treatments. The company’s shares trade on the ASX under the ticker OSL, giving it access to public capital markets to fund its clinical and commercial activities in cancer care.

This story was written using TipRanks’s AI tools and reviewed by a TipRanks editor.…Read more by TipRanks Australian Auto-Generated Newsdesk

‹ Boy with rare genetic condition meets…